Medicalsystem Biotechnology Co.,Ltd announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was CNY 531.229 million compared to CNY 440.997 million a year ago. Operating income was CNY 81.559 million compared to CNY 13.508 million a year ago. Net income was CNY 75.542 million compared to CNY 165.649 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.48 a year ago. Sales was CNY 531.229 million compared to CNY 440.997 million a year ago. Operating income was CNY 81.559 million compared to CNY 13.508 million a year ago. Net income was CNY 75.542 million compared to CNY 165.649 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.48 a year ago. For the full year, sales was CNY 2,302.032 million compared to CNY 3,133.447 million a year ago. Operating income was CNY 172.918 million compared to operating loss of CNY 525.429 million a year ago. Net income was CNY 299.480 million compared to net loss of CNY 559.912 million a year ago. Basic earnings per share from continuing operations was CNY 0.87 compared to basic loss per share from continuing operations of CNY 1.63 a year ago.